{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:36:22Z","timestamp":1793255782839,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) therapy is increasingly popular to treat musculoskeletal diseases, including tendinopathies and osteoarthritis (OA). To date, it remains unclear to which extent PRP compositions are determined by the immune cell and cytokine profile of individuals or by the preparation method. To investigate this, we compared leukocyte and cytokine distributions of different PRP products to donor blood samples and assessed the effect of pro-inflammatory cytokines on chondrocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>For each of three PRP preparations (ACP\u00ae, Angel\u2122, and nSTRIDE\u00ae APS), products were derived using whole blood samples from twelve healthy donors. The cellular composition of PRP products was analyzed by flow cytometry using DURAClone antibody panels (DURAClone IM Phenotyping Basic and DURAClone IM T Cell Subsets). The MESO QuickPlex SQ 120 system was used to assess cytokine profiles (V-PLEX Proinflammatory Panel 1 Human Kit, Meso Scale Discovery). Primary human chondrocyte 2D and 3D in vitro cultures were exposed to recombinant IFN-\u03b3 and TNF-\u03b1. Proliferation and chondrogenic differentiation were quantitatively assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All three PRP products showed elevated portions of leukocytes compared to baseline levels in donor blood. Furthermore, the pro-inflammatory cytokines IFN-\u03b3 and TNF-\u03b1 were significantly increased in nSTRIDE\u00ae APS samples compared to donor blood and other PRP products. The characteristics of all other cytokines and immune cells from the donor blood, including pro-inflammatory T cell subsets, were maintained in all PRP products. Chondrocyte proliferation was impaired by IFN-\u03b3 and enhanced by TNF-\u03b1 treatment. Differentiation and cartilage formation were compromised upon treatment with both cytokines, resulting in altered messenger ribonucleic acid (mRNA) expression of collagen type 1A1 (\n                      <jats:italic>COL1A1<\/jats:italic>\n                      ),\n                      <jats:italic>COL2A1<\/jats:italic>\n                      , and aggrecan (\n                      <jats:italic>ACAN<\/jats:italic>\n                      ) as well as reduced proteoglycan content.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individuals with elevated levels of cells with pro-inflammatory properties maintain these in the final PRP products. The concentration of pro-inflammatory cytokines strongly varies between PRP products. These observations may help to unravel the previously described heterogeneous response to PRP in OA therapy, especially as IFN-\u03b3 and TNF-\u03b1 impacted primary chondrocyte proliferation and their characteristic gene expression profile. Both the individual\u2019s immune profile and the concentration method appear to impact the final PRP product.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was prospectively registered in the Deutsches Register Klinischer Studien (DRKS) on 4 November 2021 (registration number DRKS00026175).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-022-02969-6","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T03:03:17Z","timestamp":1673319797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Individual immune cell and cytokine profiles determine platelet-rich plasma composition"],"prefix":"10.1186","volume":"25","author":[{"given":"Marcel","family":"Niemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Streitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Gr\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian N.","family":"Fleckenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Graef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"St\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Perka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg N.","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Gei\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazio","family":"Maleitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"2969_CR1","unstructured":"FDA. Part 640 - additional standards for human blood and blood products https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=640.342017\u00a0"},{"issue":"4","key":"2969_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12178-018-9527-7","volume":"11","author":"ADK Le","year":"2018","unstructured":"Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624\u201334.","journal-title":"Curr Rev Musculoskelet Med."},{"issue":"7","key":"2969_CR3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","volume":"28","author":"JM DeLong","year":"2012","unstructured":"DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998\u20131009.","journal-title":"Arthroscopy."},{"issue":"5","key":"2969_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.arthro.2014.02.020","volume":"30","author":"J Magalon","year":"2014","unstructured":"Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, et al. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014;30(5):629\u201338.","journal-title":"Arthroscopy."},{"issue":"5","key":"2969_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jos.2016.07.009","volume":"21","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi Y, Saita Y, Nishio H, Ikeda H, Takazawa Y, Nagao M, et al. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci. 2016;21(5):683\u20139.","journal-title":"J Orthop Sci."},{"issue":"7","key":"2969_CR6","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1172\/JCI124616","volume":"129","author":"M Peiseler","year":"2019","unstructured":"Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair. J Clin Invest. 2019;129(7):2629\u201339.","journal-title":"J Clin Invest."},{"issue":"12","key":"2969_CR7","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1016\/j.celrep.2018.05.057","volume":"23","author":"KM Quinn","year":"2018","unstructured":"Quinn KM, Fox A, Harland KL, Russ BE, Li J, Nguyen THO, et al. Age-related decline in primary CD8(+) T cell responses is associated with the development of senescence in virtual memory CD8(+) T cells. Cell Rep. 2018;23(12):3512\u201324.","journal-title":"Cell Rep."},{"key":"2969_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-4933-7-4","volume":"7","author":"J Yan","year":"2010","unstructured":"Yan J, Greer JM, Hull R, O'Sullivan JD, Henderson RD, Read SJ, et al. The effect of ageing on human lymphocyte subsets: comparison of males and females. Immun Ageing. 2010;7:4.","journal-title":"Immun Ageing."},{"key":"2969_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40425-017-0231-8","volume":"5","author":"MP Gustafson","year":"2017","unstructured":"Gustafson MP, DiCostanzo AC, Wheatley CM, Kim CH, Bornschlegl S, Gastineau DA, et al. A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood. J Immunother Cancer. 2017;5:30.","journal-title":"J Immunother Cancer."},{"key":"2969_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22203\/eCM.v032a10","volume":"32","author":"A Kovtun","year":"2016","unstructured":"Kovtun A, Bergdolt S, Wiegner R, Radermacher P, Huber-Lang M, Ignatius A. The crucial role of neutrophil granulocytes in bone fracture healing. Eur Cell Mater. 2016;32:152\u201362.","journal-title":"Eur Cell Mater."},{"key":"2969_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clim.2016.02.001","volume":"164","author":"OW Bastian","year":"2016","unstructured":"Bastian OW, Koenderman L, Alblas J, Leenen LP, Blokhuis TJ. Neutrophils contribute to fracture healing by synthesizing fibronectin+ extracellular matrix rapidly after injury. Clin Immunol. 2016;164:78\u201384.","journal-title":"Clin Immunol."},{"issue":"6","key":"2969_CR12","doi-asserted-by":"publisher","first-page":"e90613","DOI":"10.1371\/journal.pone.0090613","volume":"9","author":"M Liu","year":"2014","unstructured":"Liu M, Chen K, Yoshimura T, Liu Y, Gong W, Le Y, et al. Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing. PLoS One. 2014;9(6):e90613.","journal-title":"PLoS One."},{"issue":"6","key":"2969_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s10067-016-3170-8","volume":"35","author":"\u00d6 Ta\u015fo\u011flu","year":"2016","unstructured":"Ta\u015fo\u011flu \u00d6, B\u00f6l\u00fck H, \u015eahin Onat \u015e, Ta\u015fo\u011flu \u0130, \u00d6zgirgin N. Is blood neutrophil-lymphocyte ratio an independent predictor of knee osteoarthritis severity? Clin Rheumatol. 2016;35(6):1579\u201383.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2969_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12891-019-2778-7","volume":"20","author":"J Jiang","year":"2019","unstructured":"Jiang J, Liu X, Lai B, Hu D, Lai L, Xu J, et al. Correlational analysis between neutrophil granulocyte levels and osteonecrosis of the femoral head. BMC Musculoskelet Disord. 2019;20(1):393.","journal-title":"BMC Musculoskelet Disord."},{"issue":"2","key":"2969_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0363546517740845","volume":"46","author":"G Xiong","year":"2018","unstructured":"Xiong G, Lingampalli N, Koltsov JCB, Leung LL, Bhutani N, Robinson WH, et al. Men and women differ in the biochemical composition of platelet-rich plasma. Am J Sports Med. 2018;46(2):409\u201319.","journal-title":"Am J Sports Med."},{"key":"2969_CR16","unstructured":"Arthrex. ACP double syringe system 2010 [cited 2022 3rd March 2022]. Available from: https:\/\/www.brunmala.se\/files\/ACP_double_syringe_system.pdf."},{"key":"2969_CR17","unstructured":"Arthrex. PRP preparation: recommended preparation technique - Arthrex Angel\u2122 System2016 12\/07\/2021. Available from: https:\/\/www.arthrex.com\/de\/weiterfuehrende-informationen\/broschueren\/pM-GNXcgyEGL4QFHhhwnAw\/prp-preparation-recommended-preparation-technique-arthrex-angel-system."},{"key":"2969_CR18","unstructured":"Biomet Z. nSTRIDE\u00ae Autologous Protein Solution Kit 2018 [Available from: https:\/\/www.dcknee.com\/wp-content\/uploads\/nstride-autologous-protein-solution-scientific-narrative.pdf."},{"key":"2969_CR19","unstructured":"V-PLEX Proinflammatory Panel 1 Human Kit [Available from: https:\/\/www.mesoscale.com\/products\/v-plex-proinflammatory-panel-1-human-kit-k15049d\/."},{"key":"2969_CR20","doi-asserted-by":"crossref","unstructured":"Brachtl G, Poupardin R, Hochmann S, Raninger A, Jurchott K, Streitz M, et al. Batch effects during human bone marrow stromal cell propagation prevail donor variation and culture duration: impact on genotype, phenotype and function. Cells. 2022;11(6).","DOI":"10.3390\/cells11060946"},{"key":"2969_CR21","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3389\/fimmu.2019.02474","volume":"10","author":"A Andrzejewska","year":"2019","unstructured":"Andrzejewska A, Catar R, Schoon J, Qazi TH, Sass FA, Jacobi D, et al. Multi-parameter analysis of biobanked human bone marrow stromal cells shows little influence for donor age and mild comorbidities on phenotypic and functional properties. Front Immunol. 2019;10:2474.","journal-title":"Front Immunol."},{"issue":"12","key":"2969_CR22","doi-asserted-by":"publisher","first-page":"e970","DOI":"10.1038\/cddis.2013.501","volume":"4","author":"S Geissler","year":"2013","unstructured":"Geissler S, Textor M, Schmidt-Bleek K, Klein O, Thiele M, Ellinghaus A, et al. In serum veritas-in serum sanitas? Cell non-autonomous aging compromises differentiation and survival of mesenchymal stromal cells via the oxidative stress pathway. Cell Death Dis. 2013;4(12):e970.","journal-title":"Cell Death Dis."},{"issue":"177","key":"2969_CR23","doi-asserted-by":"publisher","first-page":"177ra36","DOI":"10.1126\/scitranslmed.3004754","volume":"5","author":"S Reinke","year":"2013","unstructured":"Reinke S, Geissler S, Taylor WR, Schmidt-Bleek K, Juelke K, Schwachmeyer V, et al. Terminally differentiated CD8(+) T cells negatively affect bone regeneration in humans. Sci Transl Med. 2013;5(177):177ra36.","journal-title":"Sci Transl Med."},{"issue":"7","key":"2969_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323\u201330.","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"2969_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.12998\/wjcc.v3.i2.89","volume":"3","author":"KH Fibel","year":"2015","unstructured":"Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-art management of knee osteoarthritis. World J Clin Cases. 2015;3(2):89\u2013101.","journal-title":"World J Clin Cases."},{"issue":"9991","key":"2969_CR26","first-page":"376","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet. 2015;386(9991):376\u201387.","journal-title":"Osteoarthritis. Lancet."},{"issue":"9597","key":"2969_CR27","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","volume":"370","author":"ID Learmonth","year":"2007","unstructured":"Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007;370(9597):1508\u201319.","journal-title":"Lancet."},{"issue":"4","key":"2969_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14728214.2018.1547706","volume":"23","author":"WM Oo","year":"2018","unstructured":"Oo WM, Yu SP, Daniel MS, Hunter DJ. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics. Expert Opin Emerg Drugs. 2018;23(4):331\u201347.","journal-title":"Expert Opin Emerg Drugs."},{"issue":"1_suppl","key":"2969_CR29","doi-asserted-by":"publisher","first-page":"364S","DOI":"10.1177\/1947603520931170","volume":"13","author":"G Filardo","year":"2021","unstructured":"Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A. PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage. 2021;13(1_suppl):364S\u201375S.","journal-title":"Cartilage."},{"issue":"2","key":"2969_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00264-020-04669-9","volume":"45","author":"M Sanchez","year":"2021","unstructured":"Sanchez M, Jorquera C, Sanchez P, Beitia M, Garcia-Cano B, Guadilla J, et al. Platelet-rich plasma injections delay the need for knee arthroplasty: a retrospective study and survival analysis. Int Orthop. 2021;45(2):401\u201310.","journal-title":"Int Orthop."},{"key":"2969_CR31","doi-asserted-by":"crossref","unstructured":"Woodell-May J, Steckbeck K, King W. Potential mechanism of action of current point-of-care autologous therapy treatments for osteoarthritis of the knee-a narrative review. Int J Mol Sci. 2021;22(5).","DOI":"10.3390\/ijms22052726"},{"issue":"1","key":"2969_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0363546513507766","volume":"42","author":"EA Sundman","year":"2014","unstructured":"Sundman EA, Cole BJ, Karas V, Della Valle C, Tetreault MW, Mohammed HO, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2014;42(1):35\u201341.","journal-title":"Am J Sports Med."},{"issue":"1","key":"2969_CR33","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.1038\/s41598-020-67099-y","volume":"10","author":"S Wasai","year":"2020","unstructured":"Wasai S, Sato M, Maehara M, Toyoda E, Uchiyama R, Takahashi T, et al. Characteristics of autologous protein solution and leucocyte-poor platelet-rich plasma for the treatment of osteoarthritis of the knee. Sci Rep. 2020;10(1):10572.","journal-title":"Sci Rep."},{"key":"2969_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1051\/rmr\/200002","volume":"8","author":"T Wakayama","year":"2020","unstructured":"Wakayama T, Saita Y, Kobayashi Y, Nishio H, Uchino S, Fukusato S, et al. Quality comparison between two different types of platelet-rich plasma for knee osteoarthritis. Regen Med Res. 2020;8:3.","journal-title":"Regen Med Res."},{"key":"2969_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fvets.2019.00243","volume":"6","author":"SP Franklin","year":"2019","unstructured":"Franklin SP. A pilot clinical study assessing treatment of canine hip dysplasia using autologous protein solution. Front Vet Sci. 2019;6:243.","journal-title":"Front Vet Sci."},{"key":"2969_CR36","doi-asserted-by":"crossref","unstructured":"Uchiyama R, Toyoda E, Maehara M, Wasai S, Omura H, Watanabe M, et al. Effect of platelet-rich plasma on M1\/M2 macrophage polarization. Int J Mol Sci. 2021;22(5).","DOI":"10.3390\/ijms22052336"},{"issue":"1","key":"2969_CR37","doi-asserted-by":"crossref","first-page":"232596711667527","DOI":"10.1177\/2325967116675272","volume":"5","author":"J Fitzpatrick","year":"2017","unstructured":"Fitzpatrick J, Bulsara MK, McCrory PR, Richardson MD, Zheng MH. Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med. 2017;5(1):2325967116675272.","journal-title":"Orthop J Sports Med."},{"issue":"10","key":"2969_CR38","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/0363546511417792","volume":"39","author":"EA Sundman","year":"2011","unstructured":"Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39(10):2135\u201340.","journal-title":"Am J Sports Med."},{"issue":"6","key":"2969_CR39","doi-asserted-by":"publisher","first-page":"e0156137","DOI":"10.1371\/journal.pone.0156137","volume":"11","author":"E Mariani","year":"2016","unstructured":"Mariani E, Canella V, Cattini L, Kon E, Marcacci M, Di Matteo B, et al. Leukocyte-rich platelet-rich plasma injections do not up-modulate intra-articular pro-inflammatory cytokines in the osteoarthritic knee. PLoS One. 2016;11(6):e0156137.","journal-title":"PLoS One."},{"issue":"1","key":"2969_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40634-016-0043-7","volume":"3","author":"W King","year":"2016","unstructured":"King W, van der Weegen W, Van Drumpt R, Soons H, Toler K, Woodell-May J. White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution. J Exp Orthop. 2016;3(1):9.","journal-title":"J Exp Orthop."},{"issue":"4","key":"2969_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12178-018-9516-x","volume":"11","author":"MI Kennedy","year":"2018","unstructured":"Kennedy MI, Whitney K, Evans T, LaPrade RF. Platelet-rich plasma and cartilage repair. Curr Rev Musculoskelet Med. 2018;11(4):573\u201382.","journal-title":"Curr Rev Musculoskelet Med."},{"issue":"19","key":"2969_CR42","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.2106\/JBJS.L.00019","volume":"94","author":"TM McCarrel","year":"2012","unstructured":"McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012;94(19):e143 (1-8).","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"2969_CR43","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1177\/0363546512442334","volume":"40","author":"JL Dragoo","year":"2012","unstructured":"Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012;40(6):1274\u201381.","journal-title":"Am J Sports Med."},{"issue":"12","key":"2969_CR44","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jor.22464","volume":"31","author":"A Matuska","year":"2013","unstructured":"Matuska A, O'Shaughnessey K, King W, Woodell-May J. Autologous solution protects bovine cartilage explants from IL-1alpha- and TNFalpha-induced cartilage degradation. J Orthop Res. 2013;31(12):1929\u201335.","journal-title":"J Orthop Res."},{"issue":"9","key":"2969_CR45","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/jor.21384","volume":"29","author":"J Woodell-May","year":"2011","unstructured":"Woodell-May J, Matuska A, Oyster M, Welch Z, O'Shaughnessey K, Hoeppner J. Autologous protein solution inhibits MMP-13 production by IL-1beta and TNFalpha-stimulated human articular chondrocytes. J Orthop Res. 2011;29(9):1320\u20136.","journal-title":"J Orthop Res."},{"issue":"10","key":"2969_CR46","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/jor.23528","volume":"35","author":"W King","year":"2017","unstructured":"King W, Bendele A, Marohl T, Woodell-May J. Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study. J Orthop Res. 2017;35(10):2260\u20138.","journal-title":"J Orthop Res."},{"issue":"2","key":"2969_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0363546516665809","volume":"45","author":"BJ Cole","year":"2017","unstructured":"Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45(2):339\u201346.","journal-title":"Am J Sports Med."},{"issue":"1","key":"2969_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13018-017-0521-3","volume":"12","author":"L Shen","year":"2017","unstructured":"Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):16.","journal-title":"J Orthop Surg Res."},{"issue":"5","key":"2969_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/jbmr.3062","volume":"32","author":"FA Sass","year":"2017","unstructured":"Sass FA, Schmidt-Bleek K, Ellinghaus A, Filter S, Rose A, Preininger B, et al. CD31+ cells from peripheral blood facilitate bone regeneration in biologically impaired conditions through combined effects on immunomodulation and angiogenesis. J Bone Miner Res. 2017;32(5):902\u201312.","journal-title":"J Bone Miner Res."},{"key":"2969_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12979-019-0151-1","volume":"16","author":"L Koelman","year":"2019","unstructured":"Koelman L, Pivovarova-Ramich O, Pfeiffer AFH, Grune T, Aleksandrova K. Cytokines for evaluation of chronic inflammatory status in ageing research: reliability and phenotypic characterisation. Immun Ageing. 2019;16:11.","journal-title":"Immun Ageing."},{"issue":"1","key":"2969_CR51","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/s41598-021-81382-6","volume":"11","author":"T Barker","year":"2021","unstructured":"Barker T, Rogers VE, Henriksen VT, Trawick RH, Momberger NG, Lynn RG. Circulating IL-10 is compromised in patients predisposed to developing and in patients with severe knee osteoarthritis. Sci Rep. 2021;11(1):1812.","journal-title":"Sci Rep."},{"key":"2969_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3389\/fimmu.2019.00713","volume":"10","author":"S Wendler","year":"2019","unstructured":"Wendler S, Schlundt C, Bucher CH, Birkigt J, Schipp CJ, Volk HD, et al. Immune modulation to enhance bone healing-a new concept to induce bone using prostacyclin to locally modulate immunity. Front Immunol. 2019;10:713.","journal-title":"Front Immunol."},{"key":"2969_CR53","doi-asserted-by":"crossref","unstructured":"Li IM, Liu K, Neal A, Clegg PD, Val SD, Bou-Gharios G. A cluster of regulatory elements that drives the aggrecan gene expression in chondrocytes. Osteoarthritis and Cartilage. 2016:S136\u2013S7.","DOI":"10.1016\/j.joca.2016.01.268"},{"issue":"3","key":"2969_CR54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcsm.12416","volume":"10","author":"TH Qazi","year":"2019","unstructured":"Qazi TH, Duda GN, Ort MJ, Perka C, Geissler S, Winkler T. Cell therapy to improve regeneration of skeletal muscle injuries. J Cachexia Sarcopenia Muscle. 2019;10(3):501\u201316.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"2969_CR55","doi-asserted-by":"publisher","first-page":"663978","DOI":"10.3389\/fphys.2021.663978","volume":"12","author":"J Wan","year":"2021","unstructured":"Wan J, Zhang G, Li X, Qiu X, Ouyang J, Dai J, et al. Matrix metalloproteinase 3: a promoting and destabilizing factor in the pathogenesis of disease and cell differentiation. Front Physiol. 2021;12:663978.","journal-title":"Front Physiol."},{"issue":"1","key":"2969_CR56","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar4133","volume":"15","author":"M Wang","year":"2013","unstructured":"Wang M, Sampson ER, Jin H, Li J, Ke QH, Im HJ, et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther. 2013;15(1):R5.","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"2969_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/039463201302600331","volume":"26","author":"L Lipari","year":"2013","unstructured":"Lipari L, Gerbino A. Expression of gelatinases (MMP-2, MMP-9) in human articular cartilage. Int J Immunopathol Pharmacol. 2013;26(3):817\u201323.","journal-title":"Int J Immunopathol Pharmacol."},{"issue":"1","key":"2969_CR58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13018-021-02208-9","volume":"16","author":"S Luo","year":"2021","unstructured":"Luo S, Li W, Wu W, Shi Q. Elevated expression of MMP8 and MMP9 contributes to diabetic osteoarthritis progression in a rat model. J Orthop Surg Res. 2021;16(1):64.","journal-title":"J Orthop Surg Res."},{"issue":"2","key":"2969_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1759720X16631188","volume":"8","author":"C Bottegoni","year":"2016","unstructured":"Bottegoni C, Dei Giudici L, Salvemini S, Chiurazzi E, Bencivenga R, Gigante A. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study. Ther Adv Musculoskelet Dis. 2016;8(2):35\u201341.","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"2","key":"2969_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tibtech.2016.11.001","volume":"35","author":"E Anitua","year":"2017","unstructured":"Anitua E, Prado R, Orive G. Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy? Trends Biotechnol. 2017;35(2):91\u20133.","journal-title":"Trends Biotechnol."},{"issue":"1","key":"2969_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3727\/096368912X653183","volume":"22","author":"Z-Y Zhang","year":"2013","unstructured":"Zhang Z-Y, Huang A-W, Fan JJ, Wei K, Jin D, Chen B, et al. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy. Cell transplantation. 2013;22(1):175\u201387.","journal-title":"Cell transplantation."},{"issue":"7","key":"2969_CR62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.7205\/MILMED-D-13-00336","volume":"179","author":"JR Evanson","year":"2014","unstructured":"Evanson JR, Guyton MK, Oliver DL, Hire JM, Topolski RL, Zumbrun SD, et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. Mil Med. 2014;179(7):799\u2013805.","journal-title":"Mil Med."},{"issue":"1","key":"2969_CR63","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40634-019-0175-7","volume":"6","author":"Y Taniguchi","year":"2019","unstructured":"Taniguchi Y, Yoshioka T, Sugaya H, Gosho M, Aoto K, Kanamori A, et al. Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population. J Exp Orthop. 2019;6(1):4.","journal-title":"J Exp Orthop."},{"issue":"2","key":"2969_CR64","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/iwj.13636","volume":"19","author":"B Trevisson","year":"2022","unstructured":"Trevisson B, Becerro-de-Bengoa-Vallejo R, Sevillano D, Gonz\u00e1lez N, Losa-Iglesias M, L\u00f3pez-L\u00f3pez D, et al. Age-based inter-subject variability in platelet and white blood cell concentrations of platelet-rich plasma prepared using a new application to blood separation system. International Wound J. 2022;19(2):362\u20139.","journal-title":"International Wound J"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02969-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02969-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02969-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T11:23:53Z","timestamp":1673609033000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02969-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02969-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1619463\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following institutional review committee approval (Ethikkommission Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, approval numbers EA2\/218\/21 and EA1\/146\/21) and in accordance with the Declaration of Helsinki. All participants have given written informed consent to study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}